These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30898698)

  • 1. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.
    Zhang B; Li H; Li D; Sun H; Li M; Hu H
    Gene; 2019 Jun; 700():139-148. PubMed ID: 30898698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
    Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
    Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis.
    Chen T; Meng Y; Zhou Z; Li H; Wan L; Kang A; Guo W; Ren K; Song X; Chen Y; Zhao W
    Cell Death Differ; 2023 Jul; 30(7):1829-1848. PubMed ID: 37337032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
    Zhuge B; Li G
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p.
    Yan C; Li J; Feng S; Li Y; Tan L
    Cell Death Dis; 2018 Feb; 9(3):289. PubMed ID: 29459686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
    Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
    Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
    [No Abstract]   [Full Text] [Related]  

  • 8. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
    Shen Y; Cheng L; Xu M; Wang W; Wan Z; Xiong H; Guo W; Cai M; Xu F
    Metabolism; 2023 Sep; 146():155657. PubMed ID: 37422021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.
    Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J
    Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
    Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice.
    Cossiga V; Lembo V; Nigro C; Mirra P; Miele C; D'Argenio V; Leone A; Mazzone G; Veneruso I; Guido M; Beguinot F; Caporaso N; Morisco F
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
    Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
    J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity-induced upregulation of miR-361-5p promotes hepatosteatosis through targeting Sirt1.
    Zhang Z; Liu X; Xu H; Feng X; Lin Y; Huang Y; Peng Y; Gu M
    Metabolism; 2018 Nov; 88():31-39. PubMed ID: 30309516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway.
    Liu Y; Zhou X; Xiao Y; Li C; Huang Y; Guo Q; Su T; Fu L; Luo L
    J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.
    Chen X; Tan XR; Li SJ; Zhang XX
    Life Sci; 2019 Oct; 235():116829. PubMed ID: 31484042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-1224-5p Enhances Hepatic Lipogenesis by Targeting Adenosine Monophosphate-Activated Protein Kinase α1 in Male Mice.
    Chen T; Yan D; Cheng X; Ji X; Bian J; Yin W
    Endocrinology; 2018 May; 159(5):2008-2021. PubMed ID: 29474539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathway.
    Chen L; Yu S; Hong S; Lin X; Zhu X; Cao X; Li Y; Xiao H
    Drug Dev Res; 2023 Apr; 84(2):156-171. PubMed ID: 36541217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy.
    Stacchiotti A; Grossi I; García-Gómez R; Patel GA; Salvi A; Lavazza A; De Petro G; Monsalve M; Rezzani R
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
    Wang YD; Wu LL; Mai YN; Wang K; Tang Y; Wang QY; Li JY; Jiang LY; Liao ZZ; Hu C; Wang YY; Liu JJ; Liu JH; Xiao XH
    Metabolism; 2023 Sep; 146():155660. PubMed ID: 37451670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.